Akoya Biosciences Correlations
AKYA Stock | USD 2.12 0.04 1.85% |
The current 90-days correlation between Akoya Biosciences and ATRION is -0.22 (i.e., Very good diversification). The correlation of Akoya Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Akoya Biosciences Correlation With Market
Weak diversification
The correlation between Akoya Biosciences and DJI is 0.34 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Akoya Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Akoya |
Moving together with Akoya Stock
Moving against Akoya Stock
0.43 | IVP | Inspire Veterinary | PairCorr |
0.42 | FORA | Forian Inc | PairCorr |
0.45 | VCNX | Vaccinex | PairCorr |
0.38 | BACK | IMAC Holdings | PairCorr |
0.64 | FBRX | Forte Biosciences Trending | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Akoya Stock performing well and Akoya Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Akoya Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ATRC | 1.93 | 0.51 | 0.28 | 0.51 | 1.41 | 4.67 | 23.09 | |||
ATRI | 0.39 | 0.00 | 0.00 | 0.12 | 0.00 | 0.94 | 6.29 | |||
ICUI | 1.22 | (0.01) | 0.01 | 0.09 | 1.32 | 2.87 | 7.25 | |||
HAE | 1.44 | 0.10 | 0.07 | 0.21 | 1.37 | 4.24 | 14.50 | |||
ANGO | 2.12 | (0.07) | 0.00 | 0.20 | 0.00 | 3.71 | 19.00 | |||
ATR | 0.71 | 0.13 | 0.08 | 0.31 | 0.88 | 1.47 | 7.86 | |||
COO | 0.87 | 0.07 | 0.00 | 0.30 | 0.87 | 1.39 | 13.98 | |||
INFU | 3.08 | 0.47 | 0.17 | 0.33 | 2.69 | 7.64 | 22.10 | |||
PDEX | 3.94 | 1.11 | 0.20 | 0.94 | 4.33 | 9.99 | 28.08 |
Akoya Biosciences Corporate Management
Clifford Hoyt | VP Affairs | Profile | |
Marilee MBA | Chief Officer | Profile | |
Jennifer Kamocsay | General Counsel | Profile | |
Nikolay Samusik | CoFounder | Profile | |
Priyam Shah | Senior Strategy | Profile |